Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL578113 | 1.00 | MEN1 (0.65) | MEN1TSHRKMT2ACHRM2CHRM5 | |
| SCHEMBL232820 | 1.00 | MEN1 (0.65) | MEN1TSHRKMT2ACHRM2CHRM5 | |
| Hydrochloric Acid SCHEMBL15819856 | 0.98 | MEN1 (0.63) | MEN1TSHRKMT2ACHRM2CHRM5 | |
| Hydrochloric Acid SCHEMBL17255832 | 0.98 | MEN1 (0.63) | MEN1TSHRKMT2ACHRM2CHRM5 | |
| Water SCHEMBL8812670 | 0.98 | MEN1 (0.63) | MEN1TSHRKMT2ACHRM2CHRM5 | |
| SCHEMBL13113200 | 0.93 | MEN1 (0.57) | MEN1TSHRKMT2A | |
| SCHEMBL15189362 | 0.81 | MEN1 (0.65) | MEN1TSHRKMT2ACHRM2CHRM5 | |
| SCHEMBL30819241 | 0.79 | MEN1 (1.00) | MEN1TSHRKMT2ACHRM2CHRM5 | |
| SCHEMBL1852325 | 0.79 | MEN1 (1.00) | MEN1TSHRKMT2ACHRM2CHRM5 | |
| Hydrochloric Acid SCHEMBL1340043 | 0.77 | MEN1 (0.96) | MEN1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4679086-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-20250341515-A1 | METABOLOMIC BIOMARKERS FOR ACUTE KIDNEY INJURY, ASSAYS, COMPOSITIONS AND METHODS OF USE THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-11-06 | — | — | US | claimed |
| CN-117805280-A | Ultrahigh performance liquid-mass spectrometry detection method for internal and external components of classical Ming Fang Xiaoxiangqi decoction | 陕西省中医药研究院 | 2024-04-02 | — | — | CN | claimed |
| CN-117388421-A | Method for identifying forage grass rhizosphere secretion and differential metabolite thereof based on non-targeted metabonomics | 中国农业大学 | 2024-01-12 | — | — | CN | claimed |
| EP-4679086-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-20250362309-A1 | BIOMARKERS AND USE THEREOF FOR DIAGNOSIS, PREVENTION, AND TREATMENT OF MUSCLE ATROPHY | MYOMAR MOLECULAR INC. (CA) | 2025-11-27 | — | — | US | disclosed |
| US-20250341515-A1 | METABOLOMIC BIOMARKERS FOR ACUTE KIDNEY INJURY, ASSAYS, COMPOSITIONS AND METHODS OF USE THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-11-06 | — | — | US | disclosed |
| US-20240376073-A1 | QUATERNARY AMMONIUM CATION SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS | HOFFMANN-LA ROCHE INC. (US) | 2024-11-14 | — | — | US | disclosed |
| US-12016949-B2 | Virus | IOSBIO LTD (GB) | 2024-06-25 | — | — | US | disclosed |
| CN-117805280-A | Ultrahigh performance liquid-mass spectrometry detection method for internal and external components of classical Ming Fang Xiaoxiangqi decoction | 陕西省中医药研究院 | 2024-04-02 | — | — | CN | disclosed |
| CN-117388421-A | Method for identifying forage grass rhizosphere secretion and differential metabolite thereof based on non-targeted metabonomics | 中国农业大学 | 2024-01-12 | — | — | CN | disclosed |
| CN-115389756-B | Detection kit for predicting risk of atrial fibrillation and application thereof | 首都医科大学附属北京安贞医院 | 2023-02-17 | — | — | CN | disclosed |
| US-20090092913-A1 | ADDITIVE CONTAINING PHOTOGENERATING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
| US-20090092913-A1 | ADDITIVE CONTAINING PHOTOGENERATING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
| US-20090092909-A1 | CHARGE TRAPPING RELEASER CONTAINING PHOTOGENERATING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
| US-20090092915-A1 | PHOSPHONIUM CONTAINING CHARGE TRANSPORT LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
| EP-0647133-A4 | COMPOSITIONS AND METHODS FOR ENHANCED DRUG DELIVERY. | AFFYMAX TECH NV (AN) | 1997-10-29 | — | — | EP | disclosed |
| US-5607691-A | IONTOPHORESIS | AFFYMAX TECHNOLOGIES N.V. (GB) | 1997-03-04 | — | — | US | disclosed |
| EP-0647133-A1 | COMPOSITIONS AND METHODS FOR ENHANCED DRUG DELIVERY | AFFYMAX TECHNOLOGIES N.V. (AN) | 1995-04-12 | — | — | EP | disclosed |
| WO-1993025197-A1 | COMPOSITIONS AND METHODS FOR ENHANCED DRUG DELIVERY | AFFYMAX TECHNOLOGIES N.V. (AN) | 1993-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12016949-B2 | Virus | HAVCR2, TSG101, TMEM205 | MEN1 3838/4885TSHR 4408/4885KMT2A 3872/4885 |
| US-20240376073-A1 | QUATERNARY AMMONIUM CATION SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CFTR, HRH1, HRH4 | MEN1 557/4885TSHR 648/4885KMT2A 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.